Han.biomedical Inc. (TPEX:6999)
Taiwan · Delayed Price · Currency is TWD 30.00
-1.00 (-3.23%)
At close: Jun 8, 2026
Han.biomedical Market Cap
Han.biomedical has a market cap or net worth of 660.45 million as of June 12, 2026. Its market cap has decreased by -13.65% in one year.
Market Cap
660.45M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
30.00
Market Cap Chart
Since July 31, 2024, Han.biomedical's market cap has decreased from 788.04M to 660.45M, a decrease of -16.19%. That is a compound annual growth rate of -9.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 660.45M | -18.37% |
| Dec 31, 2025 | 809.05M | 20.08% |
| Dec 30, 2024 | 673.74M | -14.51% |
| Jul 31, 2024 | 788.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 20.80B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.60B |
| Tripartite Therapeutics | 8.67B |
| Intelligene | 6.50B |
| Uwell Biopharma | 6.47B |
| Obigen Pharma | 3.93B |
| Pet Pharm Biotech | 2.88B |
| BIONET Therapeutics | 2.61B |